Absci is trading 5.8% down at $7.12 today, giving back a portion of its recent gains fueled by a broader biotech sector rally.
- The move appears to be a technical pullback as there are no fresh company headlines, earnings, or analyst updates driving the price action today.
- Previous gains on July 27 were attributed to general market strength rather than specific developments within the company.
- The stock continues to experience volatility following its recent rebound amid mixed performance across the wider markets.